Great Point Partners as of June 30, 2023
Portfolio Holdings for Great Point Partners
Great Point Partners holds 38 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alpine Immune Sciences (ALPN) | 6.8 | $35M | 3.4M | 10.28 | |
| Ultragenyx Pharmaceutical (RARE) | 6.1 | $31M | 677k | 46.13 | |
| Vaxcyte (PCVX) | 5.8 | $29M | 589k | 49.94 | |
| Pliant Therapeutics (PLRX) | 5.5 | $28M | 1.6M | 18.12 | |
| Rapt Therapeutics (RAPT) | 5.4 | $27M | 1.5M | 18.70 | |
| Point Biopharma Global | 5.3 | $27M | 3.0M | 9.06 | |
| Zura Bio Class A Ord Shs (ZURA) | 5.3 | $27M | 3.3M | 8.20 | |
| Aclaris Therapeutics (ACRS) | 4.5 | $23M | 2.2M | 10.37 | |
| Amylyx Pharmaceuticals (AMLX) | 4.1 | $21M | 969k | 21.57 | |
| Xenon Pharmaceuticals (XENE) | 4.0 | $21M | 533k | 38.50 | |
| Cytokinetics Com New (CYTK) | 3.8 | $20M | 600k | 32.62 | |
| Anaptysbio Inc Common (ANAB) | 3.6 | $18M | 894k | 20.34 | |
| Immunocore Hldgs Ads (IMCR) | 3.5 | $18M | 297k | 59.96 | |
| Evolus (EOLS) | 3.5 | $18M | 2.4M | 7.27 | |
| Aerovate Therapeutics (AVTE) | 3.1 | $16M | 932k | 17.15 | |
| Sarepta Therapeutics (SRPT) | 2.8 | $14M | 124k | 114.52 | |
| Alkermes SHS (ALKS) | 2.5 | $13M | 412k | 31.30 | |
| Rhythm Pharmaceuticals (RYTM) | 2.5 | $13M | 772k | 16.49 | |
| Optinose (OPTN) | 2.1 | $11M | 8.8M | 1.23 | |
| Viking Therapeutics (VKTX) | 1.9 | $9.7M | 599k | 16.21 | |
| Mineralys Therapeutics (MLYS) | 1.8 | $9.3M | 546k | 17.05 | |
| Amicus Therapeutics (FOLD) | 1.7 | $8.8M | 701k | 12.56 | |
| Gracell Biotechnologies Sponsored Ads | 1.7 | $8.6M | 2.3M | 3.81 | |
| Apellis Pharmaceuticals Put Option (APLS) | 1.7 | $8.6M | 95k | 91.10 | |
| Reneo Pharmaceuticals (RPHM) | 1.4 | $7.1M | 1.1M | 6.56 | |
| Intercept Pharmaceuticals In | 1.3 | $6.7M | 601k | 11.06 | |
| 4d Molecular Therapeutics In (FDMT) | 1.2 | $6.3M | 350k | 18.07 | |
| Generation Bio (GBIO) | 1.1 | $5.6M | 1.0M | 5.50 | |
| Heron Therapeutics (HRTX) | 1.1 | $5.5M | 4.7M | 1.16 | |
| Acumen Pharmaceuticals (ABOS) | 1.0 | $5.1M | 1.1M | 4.81 | |
| Igm Biosciences (IGMS) | 0.9 | $4.6M | 500k | 9.23 | |
| Seres Therapeutics (MCRB) | 0.9 | $4.5M | 938k | 4.79 | |
| Precision Biosciences Ord | 0.8 | $3.9M | 7.5M | 0.53 | |
| Solid Biosciences Com New (SLDB) | 0.6 | $3.1M | 585k | 5.24 | |
| Talaris Therapeutics | 0.4 | $2.0M | 666k | 3.04 | |
| Arcellx Common Stock (ACLX) | 0.2 | $1.2M | 38k | 31.62 | |
| Travere Therapeutics (TVTX) | 0.2 | $922k | 60k | 15.36 | |
| Mersana Therapeutics Call Option (MRSN) | 0.0 | $230k | 70k | 3.29 |
